CXCL2 and rheumatoid arthritis: Considering that promotion of neutrophil migration into the site of inflammation is critical for strengthening the cross-talk between neutrophils and FLS, identification of new inhibitors that can suppress the production of CXCL2 could be helpful in the treatment of RA.